Rexahn Pharmaceuticals Company Profile (NYSE:RNN)

About Rexahn Pharmaceuticals

Rexahn Pharmaceuticals logoRexahn Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development and commercialization of treatments for cancer. The Company's clinical-stage drug candidates in active development include Archexin, RX-3117 and Supinoxin (RX-5902). Archexin is a potent inhibitor of the protein kinase Akt-1, which focuses on cancer cell proliferation, survival, angiogenesis, metastasis and drug resistance. RX-3117 is a small molecule nucleoside compound with an anti-metabolite mechanism of action and has therapeutic potential in a range of cancers, including pancreatic, bladder, colon and lung cancer. Supinoxin is a small molecule inhibitor of phosphorylation of p68. The Company also has a drug candidate RX-21101, an N-(2-Hydroxypropyl) methacrylamide-docetaxel-folate, in pre-clinical development. The Company is working on research technologies, including multi-target aimed ligands platform and nano-based drug delivery systems.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: RNN
  • CUSIP:
Key Metrics:
  • Previous Close: $0.27
  • 50 Day Moving Average: $0.262
  • 200 Day Moving Average: $0.301
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -26.77
  • P/E Growth: 0.000
  • Market Cap: $57.17M
  • Outstanding Shares: 213,308,000
Additional Links:

Analyst Ratings

Consensus Ratings for Rexahn Pharmaceuticals (NYSE:RNN) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Rexahn Pharmaceuticals (NYSE:RNN)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Rexahn Pharmaceuticals (NYSE:RNN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2016Q216($0.02)($0.01)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Rexahn Pharmaceuticals (NYSE:RNN)
Current Year EPS Consensus Estimate: $-0.0700 EPS
Next Year EPS Consensus Estimate: $-0.0100 EPS

Dividends

Dividend History for Rexahn Pharmaceuticals (NYSE:RNN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Rexahn Pharmaceuticals (NYSE:RNN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Rexahn Pharmaceuticals (NYSE:RNN)
DateHeadline
prnewswire.com logoWhy Investors Love These Biotech's Stocks? - Cellectar Biosciences, Xenoport, Rexahn Pharma, and Tesaro (NYSE:RNN)
www.prnewswire.com - June 29 at 9:56 AM
twst.com logoRexahn Pharmaceuticals Inc.: Rexahn Pharmaceuticals to Present at the American Society of Clinical Oncology (ASCO ... - The Wall Street Transcript (NYSE:RNN)
www.twst.com - May 24 at 10:15 AM
News IconNotable movements of HC Stocks: Prima BioMed Ltd (ADR) (NASDAQ:PBMD), Rexahn Pharmaceuticals, Inc ... - share market updates (press release) (NYSE:RNN)
sharemarketupdates.com - May 23 at 11:29 AM
tradecalls.org logoRevenue Update on Rexahn Pharmaceuticals(NYSEMKT:RNN) - Trade Calls (NYSE:RNN)
www.tradecalls.org - May 20 at 6:29 PM
News IconRexahn Drugs Deal a Death Blow to Solid Tumor Cancer (NYSE:RNN)
news.investornetwork.com - May 19 at 9:20 AM
News IconHC Stocks Buzzer: Rexahn Pharmaceuticals (RNN), Aegerion Pharmaceuticals (AEGR), Electromed (ELMD) - share market updates (press release) (NYSE:RNN)
sharemarketupdates.com - May 16 at 11:30 AM
News IconRexahn Pharmaceuticals, Inc. (RNN) Forecasted to Earn FY2019 Earnings of $0.08 Per Share - Washington News Wire (NYSE:RNN)
washingtonnewswire.com - May 12 at 12:05 AM
News IconRexahn Pharmaceuticals, Inc. (RNN) Short Interest Down 24.7% in April - Washington News Wire (NYSE:RNN)
washingtonnewswire.com - May 11 at 5:02 AM
streetupdates.com logoStock's Price Moves: Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) , Carbylan Therapeutics, Inc. (NASDAQ:CBYL) - Street Updates (NYSE:RNN)
www.streetupdates.com - May 9 at 6:42 PM
News IconRexahn Pharmaceuticals Incorporated (NYSEMKT:RNN) Shorted Shares Decreased By 13.61% - B.O.D.Y Confidential (NYSE:RNN)
www.bodyconfidential.com - May 8 at 4:31 AM
biz.yahoo.com logoREXAHN PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report (NYSE:RNN)
biz.yahoo.com - May 6 at 4:31 PM
News IconBroker Outlook For Rexahn Pharmaceuticals, Inc. (RNN) - Share Trading News (NYSE:RNN)
www.sharetrading.news - May 6 at 12:15 AM
streetupdates.com logoNotable Stocks Preview: Amicus Therapeutics, Inc. (NASDAQ:FOLD) , Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) - Street Updates (NYSE:RNN)
www.streetupdates.com - May 4 at 6:47 PM
News IconBroker Outlook For The Week Ahead: Rexahn Pharmaceuticals, Inc. (RNN) - Share Trading News (NYSE:RNN)
www.sharetrading.news - May 2 at 7:07 PM
News IconLet Volatility Power Your Micro-Cap Biotechs (NYSE:RNN)
www.investorideas.com - April 29 at 12:18 AM
News IconEarnings Trends of the Stock: Rexahn Pharmaceuticals (NYSEMKT:RNN) - News Oracle (NYSE:RNN)
www.newsoracle.com - April 28 at 5:22 AM
News IconAnalyst Coverage: Rexahn Pharmaceuticals, Inc. (RNN) - Risers & Fallers (NYSE:RNN)
www.risersandfallers.com - April 27 at 7:01 PM
thepointreview.com logoStock's Buzz on These Trending Stocks BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Rexahn Pharmaceuticals, Inc ... - The Point Review (NYSE:RNN)
www.thepointreview.com - April 25 at 7:45 PM
News IconRexahn Pharmaceuticals, Inc. (RNN) Broker Price Targets For The Coming Week - Share Trading News (NYSE:RNN)
www.sharetrading.news - April 24 at 7:27 PM
News IconRexahn Pharmaceuticals, Inc. (RNN) - Broker Update - Risers & Fallers (NYSE:RNN)
www.risersandfallers.com - April 21 at 7:06 PM
News IconBroker Roundup For Rexahn Pharmaceuticals, Inc. (RNN) - Share Trading News (NYSE:RNN)
www.sharetrading.news - April 20 at 7:00 PM
smarteranalyst.com logoStock Update (NYSEMKT:RNN): Rexahn Pharmaceuticals, Inc. Presents Clinical Trial Results for Archexin® at the ... - Smarter Analyst (NYSE:RNN)
www.smarteranalyst.com - April 20 at 7:00 PM
News IconHere is What Institutional Investors Think About Rexahn Pharmaceuticals Inc (NYSEMKT:RNN) - Stock Caller (NYSE:RNN)
www.stockcaller.com - April 13 at 6:59 PM
publicnow.com logoRexahn Pharmaceuticals to Present at the 2016 American Association for Cancer Research Annual Meeting (NYSE:RNN)
www.publicnow.com - April 13 at 11:07 AM
News IconRexahn Pharmaceuticals, Inc. (RNN) Latest Broker Coverage - Risers & Fallers (NYSE:RNN)
www.risersandfallers.com - April 12 at 7:04 PM
News IconRexahn Pharmaceuticals, Inc. (RNN) Sees Large Increase in Short Interest - Washington News Wire (NYSE:RNN)
washingtonnewswire.com - April 11 at 6:54 PM
News IconAfter Last Week What Do Analysts Think Of Rexahn Pharmaceuticals, Inc. (RNN) - Share Trading News (NYSE:RNN)
www.sharetrading.news - April 10 at 6:39 PM
clintongazette.com logoRexahn Pharmaceuticals Incorporated (NYSEMKT:RNN) Shorts Decreased by 22.09% After Short Covering - Clinton Financial (NYSE:RNN)
www.clintongazette.com - April 9 at 5:31 AM
News IconNew Analyst Ratings On Rexahn Pharmaceuticals, Inc. (RNN) - Risers & Fallers (NYSE:RNN)
www.risersandfallers.com - April 9 at 12:24 AM
News IconRexahn Pharmaceuticals, Inc. (RNN) Analyst Review - Risers & Fallers (NYSE:RNN)
www.risersandfallers.com - April 6 at 9:42 AM
News IconRexahn Pharmaceuticals Incorporated (NYSEMKT:RNN) Shorted Shares Decreased By 22.09% - Stock Caller (NYSE:RNN)
www.stockcaller.com - April 5 at 12:06 AM
News IconCompany Shares of Rexahn Pharmaceuticals (NYSEMKT:RNN) Rally 5.3% - Street Edition (NYSE:RNN)
www.streetedition.net - April 4 at 10:45 AM
News IconLatest Analyst Reports On Rexahn Pharmaceuticals, Inc. - Risers & Fallers (NYSE:RNN)
www.risersandfallers.com - April 1 at 6:55 PM
clintongazette.com logoRexahn Pharmaceuticals Incorporated (NYSEMKT:RNN) Sellers Covered 22.09% of Their Shorts - Clinton Financial (NYSE:RNN)
www.clintongazette.com - March 31 at 10:21 AM
News IconRexahn Pharmaceuticals, Inc. (RNN) Earns “Buy” Rating from FBR & Co. - MicroCap Magazine (NYSE:RNN)
microcapmagazine.com - March 28 at 6:30 PM
News IconPrice Target Update: Rexahn Pharmaceuticals (RNN) - SCSUCollegian (NYSE:RNN)
www.thescsucollegian.com - March 25 at 10:16 AM
streetinsider.com logoRexahn Pharma (RNN) Announces Additional Data on Supinoxin for Treating Triple Negative Breast Cancer at TAT - StreetInsider.com (NYSE:RNN)
www.streetinsider.com - March 25 at 10:16 AM
benzinga.com logoRexahn Pharma Offers Added Data for Supinoxin for Treatment of Triple Negative Breast Cancer - Benzinga (NYSE:RNN)
www.benzinga.com - March 24 at 10:39 AM
feeds.benzinga.com logoRexahn Pharma Offers Added Data for Supinoxin for Treatment of Triple Negative Breast Cancer (NYSE:RNN)
feeds.benzinga.com - March 24 at 9:34 AM
publicnow.com logoRexahn Pharmaceuticals Presents Additional Data for Supinoxin for the Treatment of Triple Negative Breast Cancer at the 2016 Targeted Anticancer Therapeutics Congress (NYSE:RNN)
www.publicnow.com - March 24 at 9:10 AM
News IconNew Price Targets On Rexahn Pharmaceuticals, Inc. (RNN) - Risers & Fallers (NYSE:RNN)
www.risersandfallers.com - March 23 at 6:43 PM
News IconRexahn Pharmaceuticals, Inc. (RNN) New Analyst Ratings - Share Trading News (NYSE:RNN)
www.sharetrading.news - March 22 at 6:38 PM
News IconRexahn Pharmaceuticals Incorporated (NYSEMKT:RNN) Shorted Shares Increased 9.88% After Market Selling - RiversideGazette.com (NYSE:RNN)
www.riversidegazette.com - March 21 at 10:05 AM
News IconCompany Shares of Rexahn Pharmaceuticals (NYSEMKT:RNN) Drops by -11.52% - Everything HUDSON (NYSE:RNN)
www.everythinghudson.com - March 20 at 6:42 PM
News IconAnalyst Rating on Rexahn Pharmaceuticals (NYSEMKT:RNN) - Everything HUDSON (NYSE:RNN)
www.everythinghudson.com - March 18 at 6:57 PM
News IconRexahn Pharmaceuticals, Inc. (RNN) Updated Price Targets - Share Trading News (NYSE:RNN)
www.sharetrading.news - March 18 at 6:57 PM
finance.yahoo.com logoREXAHN PHARMACEUTICALS, INC. Financials (NYSE:RNN)
finance.yahoo.com - March 17 at 1:04 PM
News IconRexahn Pharmaceuticals, Inc. (RNN) New Analyst Updates - Risers & Fallers (NYSE:RNN)
www.risersandfallers.com - March 15 at 6:33 PM
kcregister.com logoWatch List: Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Bristol-Myers ... - KC Register (NYSE:RNN)
www.kcregister.com - March 14 at 7:08 PM
smarteranalyst.com logoCompany Update (NYSEMKT:RNN): Rexahn Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2015 ... - Smarter Analyst (NYSE:RNN)
www.smarteranalyst.com - March 14 at 7:08 PM

Social

Rexahn Pharmaceuticals (NYSE:RNN) Chart for Tuesday, August, 23, 2016


Last Updated on 8/23/2016 by MarketBeat.com Staff